Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
Copyright © 2021, Ahmad et al..
Regadenoson myocardial perfusion imaging (MPI) is a widely used screening study for patients with an intermediate pretest probability of coronary artery disease (CAD). Via selective agonism of the adenosine A2A receptor, regadenoson can induce coronary steal, revealing stenotic vessel territory through transient ischemia. Common side effects of this medication include chest pain, shortness of breath, nausea, vomiting, atrioventricular block, seizure, and allergic reactions. Here we present a case of severe shivering and chest tightness after the administration of regadenoson, along with a physiologic explanation and treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Cureus - 13(2021), 3 vom: 24. März, Seite e14091 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ahmad, Tanjeev [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiac stress testing |
---|
Anmerkungen: |
Date Revised 02.05.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.7759/cureus.14091 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM324811500 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM324811500 | ||
003 | DE-627 | ||
005 | 20231225191117.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7759/cureus.14091 |2 doi | |
028 | 5 | 2 | |a pubmed24n1082.xml |
035 | |a (DE-627)NLM324811500 | ||
035 | |a (NLM)33927915 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ahmad, Tanjeev |e verfasserin |4 aut | |
245 | 1 | 0 | |a Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 02.05.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2021, Ahmad et al. | ||
520 | |a Regadenoson myocardial perfusion imaging (MPI) is a widely used screening study for patients with an intermediate pretest probability of coronary artery disease (CAD). Via selective agonism of the adenosine A2A receptor, regadenoson can induce coronary steal, revealing stenotic vessel territory through transient ischemia. Common side effects of this medication include chest pain, shortness of breath, nausea, vomiting, atrioventricular block, seizure, and allergic reactions. Here we present a case of severe shivering and chest tightness after the administration of regadenoson, along with a physiologic explanation and treatment | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a cardiac stress testing | |
650 | 4 | |a drug-related side effects and adverse reactions | |
650 | 4 | |a mpi | |
650 | 4 | |a myocardial perfusion imaging | |
650 | 4 | |a regadenoson | |
650 | 4 | |a shivering | |
700 | 1 | |a Linares, Juan |e verfasserin |4 aut | |
700 | 1 | |a Valencia, Damian N |e verfasserin |4 aut | |
700 | 1 | |a Agarwal, Ajay |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cureus |d 2013 |g 13(2021), 3 vom: 24. März, Seite e14091 |w (DE-627)NLM24118083X |x 2168-8184 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2021 |g number:3 |g day:24 |g month:03 |g pages:e14091 |
856 | 4 | 0 | |u http://dx.doi.org/10.7759/cureus.14091 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2021 |e 3 |b 24 |c 03 |h e14091 |